SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-011168
Filing Date
2020-05-18
Accepted
2020-05-18 16:36:09
Documents
5
Period of Report
2020-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20200514_8k.htm 8-K 27922
2 EXHIBIT 4.1 ex_186813.htm EX-4.1 83162
3 EXHIBIT 10.1 ex_186814.htm EX-10.1 68360
4 EXHIBIT 10.2 ex_186815.htm EX-10.2 76636
5 ex_186815img001.jpg GRAPHIC 6110
  Complete submission text file 0001437749-20-011168.txt   265802
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 20890119
SIC: 2834 Pharmaceutical Preparations